HDFC Pharma and Healthcare Fund Direct Plan IDCW Reinvestment vs Bandhan BSE Healthcare Index Fund - Direct Plan - Growth
NAV, returns and costs — not a recommendation.
 HDFC Pharma and Healthcare Fund Direct Plan IDCW Reinvestment |  Bandhan BSE Healthcare Index Fund - Direct Plan - Growth | |
|---|---|---|
| NAV | ₹22.3 | ₹11.7383 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +25.46% | +14.26% |
| 3 year (p.a.) | +32.38% | +8.58% |
| 5 year (p.a.) | +32.38% | +8.58% |
| Expense ratio | 0.92% | 0.19% |
| Fund size | ₹2362.44 Cr | ₹20.21 Cr |
| Risk | — | Very high |
| Category | Sectoral Pharma and Healthcare | Index |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.